The exocyst is an octameric molecular complex that drives vesicle trafficking in adipocytes, a rate-limiting step in insulin-dependent glucose uptake. This study assessed the role of the exocyst complex in regulating free fatty acid (FFA) uptake by adipocytes. Upon differentiating into adipocytes, 3T3-L1 cells acquire the ability to incorporate extracellular FFAs in an insulin-dependent manner. A kinetic assay using fluoresceinated FFA (C12 dodecanoic acid) uptake allows the real-time monitoring of FFA internalization by adipocytes. The insulin-dependent uptake of C12 dodecanoic acid by 3T3-L1 adipocytes is mediated by Akt and phosphatidylinositol 3 (PI3)-kinase. Gene silencing of the exocyst components Exo70 and Sec8 significantly reduced insulin-dependent FFA uptake by adipocytes. Consistent with the roles played by Exo70 and Sec8 in FFA uptake, mCherry-tagged Exo70 and HA-tagged Sec8 partially colocalize with lipid droplets within adipocytes, suggesting their active roles in the development of lipid droplets. Tubulin polymerization was also found to regulate FFA uptake in collaboration with the exocyst complex. This study demonstrates a novel role played by the exocyst complex in the regulation of FFA uptake by adipocytes.
Citation: Inoue M, Akama T, Jiang Y, Chun T-H (2015) The Exocyst Complex Regulates Free Fatty Acid Uptake by Adipocytes. PLoS ONE 10(3): e0120289. doi:10.1371/journal.pone.0120289
Academic Editor: Makoto Kanzaki, Tohoku University, JAPAN
Received: August 28, 2014; Accepted: February 3, 2015; Published: March 13, 2015
Copyright: © 2015 Inoue et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Data Availability: All relevant data are included in the manuscript.
Funding: This work was supported by the American Heart Association Scientist Development Grant 0730028N (MI) and the National Institute of Health R01DK095137 (THC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Dietary lipids constitute approximately 40% of caloric intake in modern human diet . Free fatty acids (FFAs) not only serve as important energy source for ATP synthesis but also regulate intracellular signaling and transcription . FFAs in circulation are rapidly incorporated into adipocytes, hepatocytes, and cardiac myocytes . Circulating FFA levels are regulated not only by dietary FFA intake but by hormones and sympathetic tones . Dysregulated FFA handling may contribute to impaired glucose metabolism found in obese and diabetic subjects [5,6]. Therefore, defining the molecular and cellular mechanisms that regulate FFA uptake should help us better understand the pathogenesis of obesity and insulin resistance. A cohort of receptors and transporters, e.g., CD36 and fatty acid transporters (FATP) 1–4, have been shown to regulate adipocyte FFA uptake [7–12]. The plasma membrane-mediated flip-flop mechanism of FFA translocation is also suggested to regulate cellular FFA uptake [13,14]. However, the role of intracellular vesicle trafficking in the regulation of FFA uptake has not been examined to this date.
The exocyst is a large protein complex composed of Sec3 (Exoc1), Sec5 (Exoc2), Sec6 (Exoc3), Sec8 (Exoc4), Sec10 (Exoc5), Sec15 (Exoc6), Exo70 (Exoc7), and Exo84 (Exoc8). The exocyst complex was initially discovered in yeast as a molecular machinery that regulates the exocytosis of secretory vesicles . In mammalian cells, the exocyst complex promotes the translocation of glucose transporter type 4 (GLUT4) from the intracellular compartment to the plasma membrane [16–18]. Diverse biological roles of the exocyst complex have been described in different cell types including insulin secretion from pancreatic beta-cells [19,20], the trafficking of neurotransmitter receptors in synaptic terminals , and the membrane-localization of a matrix metalloproteinase (MMP) in cancer cells . In adipocytes, however, the metabolic role played by the exocyst complex beyond insulin-dependent glucose uptake has not been fully explored.
In this study, we have identified a new role for the exocyst complex in the regulation of FFA uptake by adipocytes. Our findings may shed new light on the molecular mechanism underlying FFA handling in health and diseases.
Materials and Methods
Cell culture and adipocyte differentiation
The 3T3-L1 cells (ATCC, CL-173) were maintained in DMEM, 25 mM glucose (Gibco) with 10% new born calf serum (NCS, Hyclone) in a 5% CO2 incubator at 37°C. The adipocyte differentiation of 3T3-L1 cells was induced by changing media to DMEM, 25 mM glucose with 10% fetal bovine serum (Hyclone) containing a differentiation mix (100 nM insulin, 0.25 μM dexamethasone, and 0.5 mM 3-isobutyl-1-methyxanthine, all from Sigma-Aldrich). Three days after the induction of adipogenesis, 3T3-L1 adipocytes were cultured in an optical 96-well plates with DMEM supplemented with 25 mM glucose, 100 nM insulin, and 10% FBS.
Free fatty acid uptake assay
Lipid uptake assay was performed using QBT Fatty Acid Transporter Assay Kit (Molecular Devices) according to the manufacturer’s instruction . About 50,000 cells/well/100 μL 3T3-L1 adipocytes were plated onto an optical 96 well plate (Fischer Scientific) and centrifuged at 1000 rpm for 5 min. After overnight incubation at 37°C with 5% CO2, media were changed to serum-free DMEM of high-glucose (25 mM) or low-glucose concentration (5.5 mM), and incubated for additional 1 hour. Cells were stimulated with 10 nM insulin for 30min in 1x assay buffer (1x Hank’s balanced salt solution with 20 mM HEPES and 0.2% fatty acid-free BSA) before the assay, then the fluorescent emission from each well was measured immediately after adding QBT Fatty Acid Uptake solution . The unquenched emission of intracellular BODIPY-dodecanoic acid was measured in a Victor II Multilevel Plate Reader (PerkinElmer) or Synergy Neo Multi-Mode Reader (Bio-Tek) in real time up to 3,000 seconds (λex = 480nm and λem = 515nm).
A phosphoinositide-3-kinase (PI-3K) inhibitor (Wortmannin), MEK inhibitor (U0126), mTOR inhibitor (rapamycin), Akt1/2 kinase inhibitor (Akt1/2I), and nocodazole were obtained from Sigma-Aldrich (St. Louis, MO).
Stealth RNAi transfection into adipocytes
3T3-L1 adipocytes were transfected with stealth RNA interference (RNAi) duplexes (Invitrogen) using electroporation as described before . Adipocytes at day 2 post-differentiation were detached from culture dishes with 0.25% trypsin, washed twice, and suspended in phosphate-buffered saline (PBS). Approximately 5 x 106 adipocytes were mixed with 100 nM RNAi duplexes and the electroporation was performed at 0.16 kV, 960 F with a Gene Pulser II (Bio-Rad). After electroporation, cells were incubated in DMEM with 10% FBS for 10 min at 37°C in 5% CO2 incubator for recovery. The sequences of stealth RNAi used were the following: Exo70: GCA GCU GGC UAA AGG UGA CUG ACU A, Exo70 control: GCA CGG UAA AUG UGG GUC AAC GCU A, Exo70 oligo #2: GCG CCA UCU UCC UAC ACA ACA ACU A, Exo70 oligo #2 control: GCG UCU AUC CUC ACA ACA AAC CCU A, Sec8: GGA GAU UGA ACA UGC CCU GGG ACU U, Sec8 control: GGA GUU CAA GUA CCC GGU AGG ACU U. The effectiveness of these Exo70 and Sec8 siRNA oligos was verified as described before .
Two 6-week-old C57BL/6J male mice were purchased from The Jackson Laboratory and the inguinal fat pads were isolated for cDNA cloning of mouse Exo70. Mice were euthanized with isoflurane overdose and the euthanasia was confirmed with bilateral thoracotomy. All animal procedures were approved by University Committee on Use and Care of Animals (UCUCA) of the University of Michigan.
Intracellular localization of Exo70 and lipid droplets
The mouse Exo70 cDNA was obtained from mouse (C57BL/6J) inguinal adipose tissues with RT-PCR. The mouse Exo70 cDNA was cloned into pmCherry-C1 vector (Clontech). HA-tagged Sec8 expression vector was previously described and validated . The pmCherry-Exo70 construct or HA-Sec8 was transfected into 3T3-L1 adipocytes with electroporation as described above. 48 hours after transfection, adipocytes were incubated with BODIPY 493/503 (Life Technologies) for 30 minutes and fixed in 4% paraformaldehyde in PBS. Immunofluorescent staining of HA-Sec8 was performed as described [17, 23]. Nikon A1Rsi inverted confocal laser scanning microscope with 60x/1.2 NA Plan Apochromat objective lens was used to determine the intracellular localization of mCherry-Exo70 (red, 595 nm) in relation to lipid droplets (green, 495 nm). Using sequential scanning, the lack of fluorescent bleed-through between scanned images was confirmed. Colocalization of immunofluorescence signals was assessed with ImageJ (NIH) using the plug-in Colocalization_Indices.java , which determines the colocalization of green and red signals using Pearson’s correlation coefficient  and Manders’ overlap coefficient .
Statistical data analysis
FFA uptake data were analyzed with area under curves and multiple t-tests and two-way ANOVA for time-dependent FFA uptake between samples. P-value <0.05 was considered as significant.
Real-time monitoring of FFA uptake by differentiated adipocytes
To assess the FFA uptake by adipocytes, we examined the cellular uptake of the fluorescently-labeled medium-chain FFA dodecanoic acid (BODIPY-C12-FA) [24,28]. The BODIPY-C12-FA was quenched in culture media as indicated by the lack of fluorescent emission from the extracellular space; however, once C12-FFAs were incorporated into the cytoplasm of adipocytes, the quenchers were dissociated and intracellular fluorescent emission was observed . While undifferentiated 3T3-L1 preadipocytes did not display any detectable fluorescent emission, differentiated adipocytes displayed a time-dependent and robust accumulation of BODIPY-C12-FA in the form of lipid droplets within adipocytes (Fig. 1A, 1B), which was consistent with previously reported observations [12,24].
(A) The uptake of BODIPY-C12 FA by preadipocytes and adipocytes were observed under a fluorescent microscope. Scale = 50 μm. (B) Time-dependent BODIPY-C12 FA uptake by adipocytes. Intracellular emission of BODIPY-C12 FA was monitored every 20 s up to 3,000 s in adipocytes and preadipocytes in the presence and absence of insulin (100 nM). Insulin-treated (+) and untreated (-). (C) The rate of FFA uptake was assessed with the adipocytes cultured in the presence and absence of 25 mM glucose. Blue circle (no insulin, no glucose), red square (with insulin, no glucose), green triangle (no insulin, with glucose), purple reverse triangle (with insulin, with glucose). Inset shows FFA uptake with an extended assay time. At 6,000 s, insulin-dependent FFA uptake shows the saturation of FFA uptake-dependent fluorescent signals. *P < 0.05.
To determine the kinetics of FFA uptake in real time, the fluorescent emission from unquenched fluoresceinated C12-FA was monitored using an automated fluorescent reader. When the assay time was extended to 6,000 s, the insulin-dependent increase in FFA uptake showed the signs of signal saturation (Fig. 1C, inset). The fitting to a saturation curve suggests that the time to reach the half the maximal fluorescent intensity is between 800 and 1,300 s. Therefore, following experiments were performed with assay time up to 3,000 s. The time-dependent increase of fluorescent emission following the intracellular uptake of BODIPY-C12-FA was observed only in differentiated adipocytes but not in preadipocytes (Fig. 1B), suggesting that FFA uptake is a cellular process newly acquired during adipocyte differentiation. The time course of insulin-dependent FFA uptake demonstrated that adipocyte FFA uptake begins in a liner fashion immediately after exogenous FFA are added and increases in a time-dependent manner. This adipocyte-dependent FFA uptake was increased by more than 30% in the presence of 100 nM insulin, but the effect of insulin varied depending on the degree of adipocyte differentiation (Fig. 1B). We speculated that the presence of glucose in extracellular compartment may accelerate insulin-dependent FFA uptake of adipocytes by providing glycerol . To test this possibility, we assessed the FFA uptake by adipocytes cultured in the presence and absence of extracellular glucose. Basal FFA uptake was significantly higher in adipocytes cultured in DMEM with 25 mM glucose than those cultured in DMEM without glucose, albeit with a minimal effect (area under curve, AUC, no glucose, 1.01x107 vs. with glucose, 1.14x107, P = 0.017 at t = 3,000 s); however, under an insulin-stimulated condition, adipocyte FFA uptake did not significantly differ with and without glucose (AUC, no glucose, 2.21x107; with glucose, 2.32x107, P = 0.21 at t = 3,000 s, Fig. 1C). These results suggest that insulin-dependent FFA uptake in adipocyte is not significantly altered by the presence of extracellular glucose and that insulin directly regulates FFA uptake by adipocytes.
C-12 FFA uptake by adipocytes is regulated by Phosoinositide (PI) 3-kinase and Akt
We explored the signaling pathways that are required for adipocyte FFA uptake using the kinetic assay of FFA uptake. While adipocytes were able to incorporate FFA without insulin, treatment with 100 nM insulin for 30 minutes significantly increased FFA uptake (AUC, control, 1.90 x 107; insulin treated, 2.96 x 107, P = 3.0 x 10-5 at t = 3,000 s, Fig. 2A). The inhibition of PI3-kinase activity with Wortmannin (0.4 μM) caused a substantial reduction in basal FFA uptake (AUC, 1.45 x 107, P = 0.0008 compared to control without insulin at t = 3,000 s) as well as in insulin-stimulated FFA uptake (AUC, 2.3 x 107, P = 0.0006 compared to control with insulin at t = 3,000 s) (Fig. 2A).
(A) Adipocytes were pretreated with kinase inhibitors, then stimulated with 100 nM insulin for 30 minutes before FFA uptake assay. Blue, basal FFA uptake without insulin; red, with insulin; purple and black, pretreated with Wortmaninn 0.4 μM and 4 μM; navy blue, AktI 10 μM; brown, LY294002 10 μM. N = 5 each. * P <0.01 (B) Dose-dependent suppression of insulin-dependent FFA uptake by Akt inhibitor. FFA uptake induced by 100 nM insulin with the subtraction of basal FFA uptake. N = 3 each.
These findings were replicated with another PI3-kinase inhibitor, LY294002 (10 μM) (AUC, basal condition, 1.38 x 107; insulin-stimulated condition, 2.07 x 107, P = 4.2 x 10-5 and 0.00017, compared to controls with and without insulin at t = 3,000 s). An increased dose of Wortmannin (4 μM) completely blocked the insulin-induced increase of FFA uptake (Fig. 2A, AUC 1.59 x 107, P = 4.2 x 10-6). Downstream of PI3 kinase, Akt2 plays a dominant role in adipose tissue development and function [30,31]. When adipocytes were treated with Akt inhibitor (Akt1/2I; 10 μM), FFA uptake by adipocytes was markedly suppressed to a degree similar to that observed with 4 μM Wortmannin (Fig. 2A, AUC 1.51 x 107, P = 1.6 x 10-6 compared to insulin-treated control at t = 3,000 s; P = 0.34 between Wortmannin 4 μM and Akt1/2I 10 μM). Two-way ANOVA confirmed the time-dependent (P<0.0001) and inhibitor-dependent (P<0.0001) regulation of FFA uptake. The suppressive effect of Akt inhibitor on insulin-dependent FFA uptake was found to be dose-dependent (Fig. 2B).
The exocyst complex partially colocalizes with lipid droplets
The exocyst complex plays a major role in the regulation of insulin-dependent glucose uptake . We hypothesized that exocyst-dependent vesicular trafficking may play a role in FFA uptake by adipocytes. When we examined the expression of the exocyst components before and after adipocyte differentiation, we observed the mRNA expressions of Exo70, Sec6, and Sec8 were significantly higher in differentiated adipocytes than in preadipocytes (Fig. 3A).
(A) The mRNA expression of Exo70, Sec6, and Sec8 before and after 3T3-L1 adipocyte differentiation. Pread: 3T1-L1 preadipocytes, Ad: 3T3-L1 adipocytes. (B) Upper, intracellular localization of mCherry-Exo70 (red) and lipid droplets stained with BODIPY 493/503 (green); lower, HA-Sec8 (red) and lipid droplets (green). Scale = 10 μm.
Next, we examined the localization of transfected mCherry-Exo70 and HA-Sec8 within adipocytes. The mCherry-Exo70 signals were found in intracellular vesicular structures (Fig. 3B) and were partially co-localized with intracellular lipid droplets (Fig. 3B, colocalization Pearson’s coefficient, 0.45±0.09; Manders’ overlap coefficient, 0.63±0.06, n = 7, see S1 Fig.). Similarly, HA-Sec8 partially co-localized with lipid droplets (Fig. 3B, Pearson’s coefficient, 0.34±0.06; Manders’ overlap coefficient, 0.64±0.08, n = 3).
We next aimed to determine the effect of Exo70 and Sec8 gene silencing on adipocyte FFA uptake. Gene silencing of Exo70 significantly reduced FFA uptake under both basal and insulin-treated conditions (AUC, baseline with control oligo, 3.6x107, with Exo70 siRNA, 3.1x107, P = 0.001 at t = 3,000 s; under insulin treatment, control oligo, 3.7x107; Exo70 siRNA, 3.3 x 107, P = 0.01 at t = 3,000 s) (Fig. 4A).
(A) Exo70 gene expression was suppressed (Exo70 KD) with siRNA and FFA uptake by adipocytes was assessed. Gray circle (control siRNA, no insulin), black circle (control siRNA, with 100 nM insulin), yellow triangle (Exo70 siRNA, no insulin), red triangle (Exo70 siRNA, 100 nM insulin). (B) Sec8 gene expression was silenced (Sec8 KD) and FFA uptake by adipocytes in the presence and absence of insulin was determined. Gray circle (control siRNA, no insulin), black circle (control siRNA, with 100 nM insulin), yellow triangle (Sec8 siRNA, no insulin), red triangle (Sec8 siRNA, 100 nM insulin). (C) The effect of nocodazole (Noc) treatment on FFA uptake of adipocytes. Mean ± SEM. N = 4. *P < 0.05.
Gene silencing of Sec8 also significantly suppressed basal and insulin-dependent FFA uptake by adipocytes (AUC, 3.1x107 versus 2.7x107 without insulin, P = 0.03 at t = 3,000 s; 3.5x107 versus 2.9x107 under insulin treatment, P = 0.01 at t = 3,000 s) (Fig. 4B). The intracellular localization of the exocyst complex is known to be regulated through tubulin polymerization . We therefore examined the role of microtubules in FFA uptake by disrupting tubulin polymerization using nocodazole. Treatment of adipocytes with nocodazole for 4 hours demonstrated a dose-dependent inhibition of insulin-stimulated FFA uptake (AUC, insulin-treated control, 7.9 x10-7, +nocodazole 0.5 μM, 7.5 x 10-7, P = 0.11; 5 μM, 7.3x 10-7, P = 0.03; 50 μM 6.2 x 10-7, P = 0.0001) (Fig. 4C).
The elevation of plasma FFA concentration is one of the key clinical findings observed in the patients with obesity and diabetes . The adipose tissue is the largest insulin-sensitive organ in the body which regulates the circulating level of FFA. Adipocyte size is closely correlated with adipocyte function, insulin sensitivity, and metabolism in obesity . While the exocyst complex is known to regulate the trafficking/docking of an insulin-sensitive glucose transporter, GLUT4, in adipocytes [16,17], the role of this octameric protein complex in the regulation of FFA metabolism had not been explored to this date. Our findings demonstrate for the first time that insulin-simulated FFA uptake by adipocytes is regulated through the exocyst complex (Fig. 5).
The translocation/fusion of Glut4-containing vesicles and FFA uptake are both regulated by the exocyst complex downstream of PI3-kinase and Akt. The exocyst functions in concert with other modifiers such as small GTPases, TBK1, and SNARE proteins that together coordinate adipocyte glucose uptake and FFA uptake.
Akt2 plays a dominant role in insulin-dependent glucose metabolism as well as adipose tissue development [30,31]. Insulin-dependent FFA uptake and glucose uptake are both regulated by Akt and the exocyst complex in adipocytes (Fig. 5). It is unclear, however, how the exocyst complex coordinates GLUT4 translocation/fusion and FFA uptake in adipocytes at the same time. Our FFA uptake assay with and without extracellular glucose suggest that active glucose transport under insulin-stimulated condition does not significantly interfere with insulin-dependent FFA uptake. Therefore, partial redistribution of Exo70 to the plasma membrane necessary for GLUT4 trafficking  might not significantly interfere with insulin-dependent FFA uptake (Fig. 5). The mechanism by which the exocyst complex regulates FFA uptake is unclear from this study. The exocyst may regulate 1) FFA uptake at plasma membrane, 2) the trafficking of FFA to lipid droplets, or 3) the fusion and maturation of lipid droplets. SNAP23, a t-SNARE protein [36,37], mediates the fusion of lipid droplets . Exo70 interacts with Snapin, which binds to SNAP23 . The crosstalk between SNAP23 and Exo70 may directly or indirectly regulate FFA uptake in adipocytes. Additional modifiers, such as small GTPases [16,40], may also determine the coordinated balance between glucose and FFA utilization through the exocyst complex in a cell- and tissue-specific manner (Fig. 5). RalA was found to be a key component of lipid droplets . The proteome analyses in drosophila have demonstrated the presence of Rab8 and Exo70 in lipid droplets [42,43]. Therefore, Exo70 and other members of the exocyst complex may regulate the trafficking and the fusion/maturation of lipid droplets in concert with small GTPases, such as RalA and Rab8.
The components of the exocyst complex are phosphorylated in response to insulin, EGF1, and ERK [44–46]. The role of Sec8 phosphorylation in the trafficking of GLUT4-containing vesicles has not clearly demonstrated in a previous study ; however, Sec5 phosphorylation was found to be critical for the dissociation of the exocyst complex from RalA, which then promotes the docking of GLUT4-containing vesicles to the plasma membrane . The phosphorylation of Exo70 by EGF1 via ERK1/2 promotes the assembly of the exocyst complex in HEK293 cells . Therefore, insulin as well as a subset of growth factors may regulate the assembly and disassembly of the exocyst complex through their downstream kinases. Moreover, Exo70 binds directly to Akt via TANK-binding kinase 1 (TBK1) . TBK1 plays a key role in linking inflammation to insulin resistance in obesity [48,49]. As such, the exocyst-dependent pathway may play a significant role in regulating the metabolic crosstalk between glucose uptake, lipid uptake, and inflammation within adipocytes.
To conclude, our studies have demonstrated a novel role played by the exocyst complex in facilitating insulin-dependent FFA uptake by adipocytes. This newly identified biological pathway may help us better understand the molecular mechanism by which adipocytes regulate FFA handling in health and diseases.
S1 Fig. Colocalization of Exo70 and lipid droplets in adipocytes.
Intracellular localizations of mCherry-Exo70 and lipid droplets (BODIPY 493/503) were determined by confocal microscopy. Scale = 100 μm. In each sample, 3~4 cells were analyzed. Seven samples in total were used for colocalization analysis.
We thank Richard Neubig, MD, PhD (Michigan State University) for discussion and David Buchner, Ph.D. (Case Western Reserve University) for critical reading of the manuscript.
Conceived and designed the experiments: MI TC. Performed the experiments: MI TA YJ TC. Analyzed the data: MI TA TC. Contributed reagents/materials/analysis tools: MI TC. Wrote the paper: MI TC.
- 1. Weisburger JH. Dietary fat and risk of chronic disease: mechanistic insights from experimental studies. J Am Diet Assoc. 1997; 97:S16–23 pmid:9216563
- 2. Georgiadi A, Kersten S. Mechanisms of gene regulation by fatty acids. Adv Nutr. 2012; 3:127–134 doi: 10.3945/an.111.001602. pmid:22516720
- 3. Berk PD, Stump DD. Mechanisms of cellular uptake of long chain free fatty acids. Mol Cell Biochem. 1999; 192:17–31 pmid:10331655 doi: 10.1007/978-1-4615-4929-1_3
- 4. Barter PJ, Carroll KF, Nestel PJ. Diurnal fluctuations in triglyceride, free fatty acids, and insulin during sucrose consumption and insulin infusion in man. J Clin Invest. 1971; 50:583–591 pmid:5101782 doi: 10.1172/jci106528
- 5. Groop LC, Saloranta C, Shank M, Bonadonna RC, Ferrannini E, Defronzo RA. The Role of Free Fatty Acid Metabolism in the Pathogenesis of Insulin Resistance in Obesity and Noninsulin-Dependent Diabetes Mellitus. J Clin Endocrinol Metab. 1991; 72:96–107 pmid:1986032 doi: 10.1210/jcem-72-1-96
- 6. Dresner A, Laurent D, Marcucci M, Griffin ME, Dufour S, Cline GW, et al. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest 1999; 103:253–259 pmid:9916137 doi: 10.1172/jci5001
- 7. Pohl J, Ring A, Ehehalt R, Herrmann T, Stremmel W. New concepts of cellular fatty acid uptake: role of fatty acid transport proteins and of caveolae. P Nur Soc. 2004; 63:259–262 doi: 10.1079/pns2004341
- 8. Pohl J, Ring A, Korkmaz U, Ehehalt R, Stremmel W. FAT/CD36-mediated long-chain fatty acid uptake in adipocytes requires plasma membrane rafts. Mol Biol Cell. 2005; 16:24–31 pmid:15496455 doi: 10.1091/mbc.e04-07-0616
- 9. Hirsch D, Stahl A, Lodish HF. A family of fatty acid transporters conserved from mycobacterium to man. Proc Natl Acad Sci USA 1998; 95:8625–8629 pmid:9671728 doi: 10.1073/pnas.95.15.8625
- 10. Wu Q, Ortegon AM, Tsang B, Doege H, Feingold KR, Stahl A. FATP1 is an insulin-sensitive fatty acid transporter involved in diet-induced obesity. Mol Cell Biol 2006; 26:3455–3467 pmid:16611988 doi: 10.1128/mcb.26.9.3455-3467.2006
- 11. Kampf JP, Parmley D, Kleinfeld AM. Free fatty acid transport across adipocytes is mediated by an unknown membrane protein pump. Am J Physiol-Endoc M. 2007; 293:E1207–1214 pmid:17711989 doi: 10.1152/ajpendo.00259.2007
- 12. Stahl A, Evans JG, Pattel S, Hirsch D, Lodish HF. Insulin Causes Fatty Acid Transport Protein Translocation and Enhanced Fatty Acid Uptake in Adipocytes. Dev Cell 2002; 2:477–488 pmid:11970897 doi: 10.1016/s1534-5807(02)00143-0
- 13. Kamp F, Guo W, Souto R, Pilch PF, Corkey BE, Hamilton JA. Rapid Flip-flop of Oleic Acid across the Plasma Membrane of Adipocytes. J Biol Chem. 2003; 278:7988–7995 pmid:12499383 doi: 10.1074/jbc.m206648200
- 14. Xu S, Jay A, Brunaldi K, Huang N, Hamilton JA. CD36 Enhances Fatty Acid Uptake by Increasing the Rate of Intracellular Esterification but Not Transport across the Plasma Membrane. Biochemistry. 2013; 52:7254–7261 doi: 10.1021/bi400914c. pmid:24090054
- 15. TerBush DR, Maurice T, Roth D, Novick P. The Exocyst is a multiprotein complex required for exocytosis in Saccharomyces cerevisiae. EMBO J. 1996; 15:6483–6494 pmid:8978675
- 16. Inoue M, Chang L, Hwang J, Chiang SH, Saltiel AR. The exocyst complex is required for targeting of Glut4 to the plasma membrane by insulin. Nature 2003; 422:629–633 pmid:12687004 doi: 10.1038/nature01533
- 17. Inoue M, Chiang SH, Chang L, Chen XW, Saltiel AR. Compartmentalization of the exocyst complex in lipid rafts controls Glut4 vesicle tethering. Mol Biol Cell 2006; 17:2303–2311 pmid:16525015 doi: 10.1091/mbc.e06-01-0030
- 18. Ewart M-A, Clarke M, Kane S, Chamberlain LH, Gould GW. Evidence for a Role of the Exocyst in Insulin-stimulated Glut4 Trafficking in 3T3-L1 Adipocytes. J Biol Chem. 2005; 280:3812–3816 pmid:15550383 doi: 10.1074/jbc.m409928200
- 19. Tsuboi T, Ravier MA, Xie H, Ewart MA, Gould GW, Baldwin SA, et al. Mammalian exocyst complex is required for the docking step of insulin vesicle exocytosis. J Biol Chem. 2005; 280:25565–25570 pmid:15878854 doi: 10.1074/jbc.m501674200
- 20. Xie L, Zhu D, Kang Y, Liang T, He Y, Gaisano HY. Exocyst sec5 regulates exocytosis of newcomer insulin granules underlying biphasic insulin secretion. PloS One. 2013; 8:e67561 doi: 10.1371/journal.pone.0067561. pmid:23844030
- 21. Sans N, Prybylowski K, Petralia RS, Chang K, Wang YX, Racca C, et al. NMDA receptor trafficking through an interaction between PDZ proteins and the exocyst complex. Nat Cell Biol. 2003; 5:520–530 pmid:12738960 doi: 10.1038/ncb990
- 22. Sakurai-Yageta M, Recchi C, Le Dez G, Sibarita JB, Daviet L, Camonis J, et al. The interaction of IQGAP1 with the exocyst complex is required for tumor cell invasion downstream of Cdc42 and RhoA. J Cell Biol. 2008; 181:985–998 doi: 10.1083/jcb.200709076. pmid:18541705
- 23. Chun TH, Inoue M. 3-D adipocyte differentiation and peri-adipocyte collagen turnover. Method Enzymol. 2014; 538:15–34 doi: 10.1016/B978-0-12-800280-3.00002-5. pmid:24529431
- 24. Liao J, Sportsman R, Harris J, Stahl A. Real-time quantification of fatty acid uptake using a novel fluorescence assay. J Lipid Res. 2005; 46:597–602 pmid:15547301 doi: 10.1194/jlr.d400023-jlr200
- 25. Nakamura K, Watakabe A, Hioki H, Fujiyama F, Tanaka Y, Yamamori T, et al. Transiently increased colocalization of vesicular glutamate transporters 1 and 2 at single axon terminals during postnatal development of mouse neocortex: a quantitative analysis with correlation coefficient. Eur J Neurosci. 2007; 26:3054–3067 pmid:18028110 doi: 10.1111/j.1460-9568.2007.05868.x
- 26. Manders EM, Stap J, Brakenhoff GJ, van Driel R, Aten JA. Dynamics of three-dimensional replication patterns during the S-phase, analysed by double labelling of DNA and confocal microscopy. J Cell Sci. 1992; 103 (Pt 3):857–862 pmid:1478975
- 27. Manders EMM, Verbeek FJ, Aten JA. Measurement of co-localization of objects in dual-colour confocal images. J Microsc. 1993; 169:375–382 doi: 10.1111/j.1365-2818.1993.tb03313.x
- 28. Dubikovskaya E, Chudnovskiy R, Karateev G, Park HM, Stahl A. Chapter Seven—Measurement of Long-Chain Fatty Acid Uptake into Adipocytes. In: Ormond AM, ed. Methods Enzymol. Vol Volume 538: Academic Press; 2014:107–134. doi: 10.1016/B978-0-12-800280-3.00007-4. pmid:24529436
- 29. Franckhauser S, Muñoz S, Pujol A, Casellas A, Riu E, Otaegui P, et al. Increased Fatty Acid Re-esterification by PEPCK Overexpression in Adipose Tissue Leads to Obesity Without Insulin Resistance. Diabetes 2002; 51:624–630 pmid:11872659 doi: 10.2337/diabetes.51.3.624
- 30. Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, Crenshaw EB, et al. Insulin Resistance and a Diabetes Mellitus-Like Syndrome in Mice Lacking the Protein Kinase Akt2 (PKBβ). Science 2001; 292:1728–1731 pmid:11387480 doi: 10.1126/science.292.5522.1728
- 31. Peng X-d, Xu P-Z, Chen M-L, Hahn-Windgassen A, Skeen J, Jacobs J, et al. Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Gene Dev. 2003; 17:1352–1365 pmid:12782654 doi: 10.1101/gad.1089403
- 32. Liu J, Yue P, Artym VV, Mueller SC, Guo W. The Role of the Exocyst in Matrix Metalloproteinase Secretion and Actin Dynamics during Tumor Cell Invadopodia Formation. Mol Biol Cell. 2009; 20:3763–3771 doi: 10.1091/mbc.E08-09-0967. pmid:19535457
- 33. Chen Y-D, Golay A, Swislocki A, Reaven GM. Resistance to Insulin Suppression of Plasma Free Fatty Acid Concentrations and Insulin Stimulation of Glucose Uptake in Noninsulin-Dependent Diabetes Mellitus. J Clin Endocrinol Metab. 1987; 64:17–21 pmid:3782431 doi: 10.1210/jcem-64-1-17
- 34. Lewis GF, Carpentier A, Adeli K, Giacca A. Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes. Endocr Rev. 2002; 23:201–229 pmid:11943743 doi: 10.1210/edrv.23.2.0461
- 35. Lizunov VA, Matsumoto H, Zimmerberg J, Cushman SW, Frolov VA. Insulin stimulates the halting, tethering, and fusion of mobile GLUT4 vesicles in rat adipose cells. J Cell Biol. 2005; 169:481–489 pmid:15866888 doi: 10.1083/jcb.200412069
- 36. Ravichandran V, Chawla A, Roche PA. Identification of a Novel Syntaxin- and Synaptobrevin/VAMP-binding Protein, SNAP-23, Expressed in Non-neuronal Tissues. J Biol Chem 1996; 271:13300–13303 pmid:8663154 doi: 10.1074/jbc.271.23.13300
- 37. Jahn R, Scheller RH. SNAREs—engines for membrane fusion. Nat Rev Mol Cell Biol 2006; 7:631–643 pmid:16912714 doi: 10.1038/nrm2002
- 38. Bostrom P, Andersson L, Rutberg M, Perman J, Lidberg U, Johansson BR, et al. SNARE proteins mediate fusion between cytosolic lipid droplets and are implicated in insulin sensitivity. Nat Cell Biol. 2007; 9:1286–1293 pmid:17922004 doi: 10.1038/ncb1648
- 39. Bao Y, Lopez JA, James DE, Hunziker W. Snapin Interacts with the Exo70 Subunit of the Exocyst and Modulates GLUT4 Trafficking. J Biol Chem. 2008; 283:324–331 pmid:17947242 doi: 10.1074/jbc.m706873200
- 40. Chen XW, Leto D, Chiang SH, Wang Q, Saltiel AR. Activation of RalA is required for insulin-stimulated Glut4 trafficking to the plasma membrane via the exocyst and the motor protein Myo1c. Dev Cell 2007; 13:391–404 pmid:17765682 doi: 10.1016/j.devcel.2007.07.007
- 41. Liu P, Ying Y, Zhao Y, Mundy DI, Zhu M, Anderson RGW. Chinese Hamster Ovary K2 Cell Lipid Droplets Appear to Be Metabolic Organelles Involved in Membrane Traffic. J Biol Chem. 2004; 279:3787–3792 pmid:14597625 doi: 10.1074/jbc.m311945200
- 42. Cermelli S, Guo Y, Gross SP, Welte MA. The Lipid-Droplet Proteome Reveals that Droplets Are a Protein-Storage Depot. Curr Biol. 2006; 16:1783–1795 pmid:16979555 doi: 10.1016/j.cub.2006.07.062
- 43. Krahmer N, Hilger M, Kory N, Wilfling F, Stoehr G, Mann M, et al. Protein Correlation Profiles Identify Lipid Droplet Proteins with High Confidence. Mol Cell Proteomics. 2013; 12:1115–1126 doi: 10.1074/mcp.M112.020230. pmid:23319140
- 44. Lyons PD, Peck GR, Kettenbach AN, Gerber SA, Roudaia L, Lienhard GE. Insulin stimulates the phosphorylation of the exocyst protein Sec8 in adipocytes. Bioscience Rep. 2009; 29:229–235 doi: 10.1042/BSR20080162. pmid:19006485
- 45. Chen XW, Leto D, Xiao J, Goss J, Wang Q, Shavit JA, et al. Exocyst function is regulated by effector phosphorylation. Nat Cell Biol. 2011; 13:580–588 doi: 10.1038/ncb2226. pmid:21516108
- 46. Ren J, Guo W. ERK1/2 regulate exocytosis through direct phosphorylation of the exocyst component Exo70. Dev Cell. 2012; 22:967–978 doi: 10.1016/j.devcel.2012.03.005. pmid:22595671
- 47. Ou YH, Torres M, Ram R, Formstecher E, Roland C, Cheng T, et al. TBK1 directly engages Akt/PKB survival signaling to support oncogenic transformation. Mol Cell 2011; 41:458–470 doi: 10.1016/j.molcel.2011.01.019. pmid:21329883
- 48. Munoz MC, Giani JF, Mayer MA, Toblli JE, Turyn D, Dominici FP. TANK-binding kinase 1 mediates phosphorylation of insulin receptor at serine residue 994: a potential link between inflammation and insulin resistance. J Endocrinol. 2009; 201:185–197 doi: 10.1677/JOE-08-0276. pmid:19251743
- 49. Reilly SM, Chiang SH, Decker SJ, Chang L, Uhm M, Larsen MJ, et al. An inhibitor of the protein kinases TBK1 and IKK-varepsilon improves obesity-related metabolic dysfunctions in mice. Nat Med 2013; 19:313–321 doi: 10.1038/nm.3082. pmid:23396211